They also offered preliminary evidence that LSD1 was implicated in drug resistance, as they found it to be over-expressed in chemoresistant breast cancer cell lines and tumor cells that survived in mouse xenografts after prolonged docetaxel treatment and displayed increased levels of stemness genes, EMT regulators and resistance markers. The gene discussed is KDM1A; the disease is breast cancer.